Antiinflammatory activity of alpha-methyl-3-phenyl-7-benzofuranacetic acid (R-803)

Area of Science:

• Pharmacology
• Inflammation Research

Background:

• Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for managing inflammatory conditions.
• There is a continuous need for novel anti-inflammatory agents with improved efficacy and safety profiles.

Purpose of the Study:

• To evaluate the anti-inflammatory activity of a new nonsteroidal compound, R-803 (alpha-methyl-3-phenyl-7-benzofuranacetic acid).

Main Methods:

• Oral administration of R-803 in various animal models of inflammation.
• Assessment of R-803's effect on carrageenan-induced paw edema in rats.
• Evaluation of R-803's impact on ultraviolet-induced erythema in guinea pigs.
• Testing R-803's efficacy in adjuvant-induced and 6-sulfonamidoindazole-induced arthritis models in rats.
• Inhibition of cotton pellet-induced granuloma formation in rats was also assessed.

Main Results:

• R-803 demonstrated significant inhibition of carrageenan-induced paw edema.
• The compound effectively reduced ultraviolet-induced erythema.
• R-803 showed notable anti-arthritic effects in both adjuvant-induced and 6-sulfonamidoindazole-induced arthritis models.
• Anti-inflammatory activity was observed at oral doses ranging from 1.0 to 6.0 mg/kg for most models.
• Higher doses were required to inhibit cotton pellet-induced granuloma.

Conclusions:

• R-803 exhibits potent anti-inflammatory activity across multiple preclinical models.
• The findings support R-803 as a promising candidate for further development as a nonsteroidal anti-inflammatory drug.